1 |
姚咏明,盛志勇. 脓毒症研究的若干新动态[J]. 中国危重病急救医学,2000,12(6):323-325.
|
2 |
陈绪军,肖琦,艾中立,等. 肝细胞损伤、细胞凋亡及肝细胞保护[J].国外医学外科学分册,2000,27(1):21-24.
|
3 |
马晓春. 应提高对脓毒症肝损伤的认识[J]. 中华危重病急救医学,2013,25(4):198-200.
|
4 |
陶佩,尹海燕,马永辉. 姜黄素对脓毒症大鼠肝细胞线粒体膜通透性转换的作用机制研究[J]. 中华危重病急救医学,2014,26(9):666-670.
|
5 |
Guan J, Jin DD, Jin LJ, et al. Apoptosis in organs of rats in early stage after polytrauma combined with shock[J]. J Trauma, 2002, 52 (1): 104-111.
|
6 |
Tsamandas AC, Thomopoulos K, Zolota V, et al. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study[J]. Mod Pathol, 2003, 16 (12): 1273-1288.
|
7 |
Zhang M, He W, Liu F, et al. Inhibition of mouse hepatocyte apoptosis via anti-Fas ribozyme[J]. World J Gastroenterol, 2004, 10 (17): 2567-2570.
|
8 |
Kienle K, Rentsch M, Müller T, et al. Expression of BCL-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and repedusion in rat liver transplantation[J]. Transplant Proc, 2005, 37 (1): 439-441.
|
9 |
Wang XZ, Zhang SJ, Chen YX, et al. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro[J]. World J Gastroenterol, 2004, 10 (18): 2706-2710.
|
10 |
Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability[J]. Cell Death Differ, 2000, 7 (12): 1182-1191.
|
11 |
郭剑颖,邓群,郭旭升,等. 乌司他丁和胸腺肽α1联合治疗严重脓毒症的组织病理学观察[J]. 南方医科大学学报,2012,32(6):830-834.
|
12 |
尹海燕,主有峰,陶珮,等. 姜黄素对脓毒症大鼠肝细胞的剂量保护效应[J]. 中华危重病急救医学,2016,28(3):252-256.
|
13 |
Huang N, Wang F, Wang Y, et al. Ulinastatin improves survival of septic mice by suppressing inflammatory response and lymphocyte apoptosis[J]. J Surg Res, 2013, 182 (2): 296-302.
|
14 |
卢化祥,贾一韬,俞为荣,等. 乌司他丁对小鼠不同程度肠缺血-再灌注损伤的用[J]. 上海交通大学学报(医学版),2014,34(5):626-630.
|
15 |
孙来芳,潘利伟. 乌司他丁影响严重脓毒症大鼠IL-10、TNF-α、IL-1β水平的研究[J]. 临床外科杂志,2005,13(12):770-772.
|
16 |
邓秋明,陈爱和,尚东. Bc-xL及Bax表达变化在大黄素影响脓毒症患者中性粒细胞凋亡中的作用[J]. 中国中西医结合急救杂志,2016,23(2):129-132.
|
17 |
Cao YZ, Tu YY, Chen X, et al. Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13[J]. Exp Toxicol Pathol, 2012, 64 (6): 543-547.
|
18 |
Tanaka R, Fujita M, Tsuruta R,et al. Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats[J]. Inflamm Res, 2010, 59 (8): 597-606.
|
19 |
周密,张明瑜,许晓东,等. 乌司他丁预先给药对大鼠海马CA1区缺血-再灌注损伤的干预研究[J/CD]. 中华危重症医学杂志(电子版),2015,8(1):24-28.
|
20 |
李莉,古正涛,刘志锋,等. 活性氧调控Bcl-2、Bax表达参与热打击后人脐静脉内皮细胞凋亡的研究[J].中华危重病急救医学,2014,26(7):458-463.
|
21 |
李仕军,闻飞英. 乌司他丁对严重脓毒症患者血乳酸及乳酸清除率的早期影响[J/CD].中华危重症医学(电子版),2013,6(2):98-101.
|
22 |
Zhang C, Wang Y, Fu W, et al. A Meta-analysis on the effect of ulinastatin on serum levels of C-reactive protein, interleukin 6,and tumor necrosis factor alpha in Asian patients with acute pancreatitis[J]. Genet Test Mol Biomarkers, 2016,20 (3): 118-124.
|
23 |
Atal SS, Atal S. Ulinastatin-a newer potential thera-peutic option for multiple organ dysfunction syndrome [J]. J Basic Clin Physiol Pharmacol, 2016, 27 (2): 9199.
|
24 |
Han D, Shang W, Wang G, et al. Ulinastatin-and thymosin α1-based immunomodulatory strategy for sepsis: A meta-analysis [J]. Int Immunopharmacol, 2015, 29 (2): 377-82.
|